Stocks · News reference

Invivyd shares are trading lower. The company announced the appointment of Marc Elia as its CEO and said it continues to expect top-line data from the VYD2311 program around the end of Q3 2026.

Sep 1, 2026, 4:20 PMBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

SEC EDGARSep 1, 2026, 11:10 AMSEC EDGAR
8-K filing — Invivyd, Inc. (IVVD)
Filed: 2026-09-01 AccNo: 0001193125-26-377493 Size: 1 MB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
IVVD
BenzingaSep 1, 2026, 11:10 AMBenzinga Newsdesk
Invivyd Continues To Expect Top-Line Data From VYD2311 Program Around The End Of Q3 2026
Invivyd continues to expect top-line data from the VYD2311 program around the end of Q3 2026. At that time, Invivyd plans to either unblind the DECLARATION study in its entirety and submit a Biologics License
IVVD
BenzingaSep 1, 2026, 11:08 AMBenzinga Newsdesk
Invivyd Appoints Marc Elia As CEO
Mr. Elia has served as Chairman of Invivyd’s Board of Directors since June of 2022; has architected Invivyd’s scientific and corporate strategyAjay Royan, Founder of Mithril Capital and a founding, long-term investor in
IVVD